$300-500M to bring TAVR to the market???? The development cost of the product has already been done with the clinical trials currently occurring, possibly need $50M for commercialisation if AVR plan to go it alone again like what they did with ADAPT but IMO WP has learnt that to get into the surgery medical device market, the best strategy is to partner with existing company as they've already generated the market brand after many years.
New AVR detailed research report with valuations, page-50
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.14 |
Change
0.000(0.00%) |
Mkt cap ! $277.7M | |||
| Open | High | Low | Value | Volume |
| $13.33 | $13.91 | $13.14 | $302.2K | 22.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 299 | $13.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.49 | 35 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |